Arbutus Biopharma Corp Live Stock Price Today, Share Analysis and Chart

Name: Arbutus Biopharma Corp: Is Infosys Ltd. worth buying?
Item: Arbutus Biopharma Corp
Rating: 1.30925
Author: Trendlyne DVM scores

about

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can b...

4.35 0.04 (0.93%)

47.96% Gain from 52W Low

924.9K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Arbutus Biopharma Corp is on 21 May 2026 for the purpose of Arbutus Biopharma Corp Annual General Meeting for 2026 See details

Not Eligible

Expensive Valuation

5.0 / 100

Technically Neutral

47.4 / 100

1Yr Price target upside is 20%

3 analysts

Arbutus Biopharma Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Arbutus Biopharma Corp Live Stock Price Today, Share Analysis and Chart

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can b...

47.96% Gain from 52W Low

SWOT Analysis

Arbutus Biopharma Corp Live Price Chart